Literature DB >> 3928029

Genetic heterogeneity in acute intermittent porphyria: characterisation and frequency of porphobilinogen deaminase mutations in Finland.

P Mustajoki, R J Desnick.   

Abstract

The occurrence of different porphobilinogen deaminase mutant types in 68 patients with acute intermittent porphyria from 33 unrelated families in Finland was studied with biochemical and immunological techniques. In this fairly homogenous population four different porphobilinogen deaminase mutant types were identified and their frequencies determined. Most (about 80%) of the mutations were cross reacting immunological material (CRIM) negative, including a large kindred with normal erythrocyte porphobilinogen deaminase activities. The remainder of the families had CRIM positive mutations, including an unusual type (type 2) that had an immunoreactive, non-catalytic porphobilinogen deaminase level considerably greater than the maximal theoretical ratio of CRIM to activity of 2.0 for a single mutant allele. Correlations of the amount of residual porphobilinogen deaminase activity and the occurrence of acute clinical manifestations in each mutant type suggested that CRIM positive type 2 patients may have fewer acute symptoms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928029      PMCID: PMC1416521          DOI: 10.1136/bmj.291.6494.505

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Purification and properties of delta-aminolevulinate dehydrase from human erythrocytes.

Authors:  P M Anderson; R J Desnick
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

2.  The Finnish population structure. A genetic and genealogical study.

Authors:  H R Nevanlinna
Journal:  Hereditas       Date:  1972       Impact factor: 3.271

3.  Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism.

Authors:  U A Meyer; L J Strand; M Doss; A C Rees; H S Marver
Journal:  N Engl J Med       Date:  1972-06-15       Impact factor: 91.245

4.  The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.

Authors:  K Miyagi; R Cardinal; I Bossenmaier; C J Watson
Journal:  J Lab Clin Med       Date:  1971-11

5.  Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrate.

Authors:  R J Desnick; L T Ostasiewicz; P A Tishler; P Mustajoki
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Biosynthesis of the pigments of life: formation of the macrocycle.

Authors:  A R Battersby; C J Fookes; G W Matcham; E McDonald
Journal:  Nature       Date:  1980-05-01       Impact factor: 49.962

7.  Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.

Authors:  P M Anderson; R M Reddy; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

8.  Hereditary hepatic porphyrias in Finland.

Authors:  P Mustajoki; P Koskelo
Journal:  Acta Med Scand       Date:  1976

9.  Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity.

Authors:  L J Strand; B F Felsher; A G Redeker; H S Marver
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

10.  Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.

Authors:  R E Ford; C N Ou; R D Ellefson
Journal:  Clin Chem       Date:  1980-07       Impact factor: 8.327

View more
  6 in total

1.  RFLP analysis of three different types of acute intermittent porphyria.

Authors:  R Kauppinen; L Peltonen; A Palotie; P Mustajoki
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

2.  Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.

Authors:  H Puy; J C Deybach; J Lamoril; A M Robreau; V Da Silva; L Gouya; B Grandchamp; Y Nordmann
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

3.  Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria.

Authors:  Brenden Chen; Constanza Solis-Villa; Angelika L Erwin; Manisha Balwani; Irina Nazarenko; John D Phillips; Robert J Desnick; Makiko Yasuda
Journal:  J Inherit Metab Dis       Date:  2019-01       Impact factor: 4.982

4.  Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.

Authors:  C H Chen; K H Astrin; G Lee; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Detection of seven point mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria, by direct sequencing of in vitro amplified cDNA.

Authors:  C S Mgone; W G Lanyon; M R Moore; J M Connor
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

6.  Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism.

Authors:  Helene J Bustad; Juha P Kallio; Mikko Laitaoja; Karen Toska; Inari Kursula; Aurora Martinez; Janne Jänis
Journal:  iScience       Date:  2021-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.